Citation

Angst D, Gessier F, Janser P, Vulpetti A, Wälchli R, Beerli C, Littlewood-Evans A, Dawson J, Nuesslein-Hildesheim B, Wieczorek G, Gutmann S, Scheufler C, Hinniger A, Zimmerlin A, Funhoff EG, Pulz R, Cenni B.: Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase. J Med Chem, Volume 63 (10), 2020

Authors

Angst D, Beerli C, Cenni B., Dawson J, Funhoff EG, Gessier F, Gutmann S, Hinniger A, Janser P, Littlewood-Evans A, Nuesslein-Hildesheim B, Pulz R, Scheufler C, Vulpetti A, Wälchli R, Wieczorek G, Zimmerlin A

Journal

J Med Chem

Year

2020

DOI

10.1021/acs.jmedchem.9b01916

PubMed

32083858

Machine-readable

REST APIRDF